Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Charles Mcwherter currently holds 67,700 shares of CymaBay Therapeutics, Inc. (CBAY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Charles Mcwherter has been a net seller of CBAY stock. They have purchased $91.9K and sold $2.4M worth of shares.
Charles Mcwherter's most recent insider trade was on Oct 30, 2025, when they sold 25,000 shares at $0.00 per share.
Charles Mcwherter serves as Executive at CymaBay Therapeutics, Inc. (CBAY). They have executed 60 insider transactions totaling $2.5M over their tenure at the company.
Charles Mcwherter holds the position of Executive at CymaBay Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Charles Mcwherter has shown a selling trading pattern, with $91.9K in total purchases and $2.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Charles Mcwherter was on Sep 18, 2023, when they sold $352.7K worth of CBAY shares. This transaction involved 21,746 shares at $16.22 per share.
Charles Mcwherter currently owns 67,700 shares of CymaBay Therapeutics, Inc. (CBAY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Charles Mcwherter's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Charles Mcwherter has 60 Form 4 filings on record as an insider at CymaBay Therapeutics, Inc..
Set alerts for Charles Mcwherter and 40,000+ other insiders.